AAIC Investment Pte. Ltd. (Headquarters: Singapore; Representative: Susumu Tsubaki; hereinafter referred to as "AAIC Investment") is pleased to announce that Aumet, a portfolio company of our "Africa Innovation & Healthcare Fund II (hereinafter "AHF2")", has completed a Series A funding round, raising a total of US$12 million.

Aumet is a Jordan-based, Saudi Arabia-based health tech company that develops AI-powered healthcare procurement and supply chain platforms. Through its proprietary platform that integrates pharmaceutical and medical device procurement, inventory management, and data analytics, Aumet digitally connects pharmacies, hospitals, and pharmaceutical suppliers, driving efficiency improvements in healthcare distribution infrastructure in the Middle East and North Africa (MENA) region.

Currently, Aumet's platform is used by more than 12,000 pharmacies and over 1,000 pharmaceutical suppliers, primarily in Jordan, Egypt, and Saudi Arabia, and has grown to support more than 5 million transactions annually and a cumulative gross merchandise volume (GMV) exceeding US$1 billion.

Furthermore, Aumet is expanding its business beyond being merely a medical marketplace, becoming an AI-powered healthcare procurement operating system. Its main services include "Pulse," a cloud-based inventory management and procurement support platform for individual pharmacies; "Chain," a centralized purchasing and AI analytics solution for pharmacy chains; and "Enterprise," an AI-powered healthcare procurement system for hospitals and government agencies.

“Enterprise” has been implemented in Jordan's public healthcare system, starting with its introduction at Al Bashir Hospital, one of the country's largest public hospitals. Currently, it is installed in 32 hospitals, over 500 medical centers, and more than 18 medical warehouses. A key feature is its promotion of national-level digital transformation of healthcare infrastructure through collaboration with the Jordanian Ministry of Health and the Ministry of Digital Economy and Entrepreneurship.

The funds raised will be used to enhance our AI capabilities, expand our enterprise business, enter new markets including the GCC (Gulf Cooperation Council) countries, and accelerate our global expansion.

Since 2017, AAIC has been promoting investments in the healthcare and innovation sectors, primarily in Africa and the Middle East, and will continue to support startups that contribute to improving access to healthcare and healthcare infrastructure in emerging countries.

●AAIC Investment

Company name: AAIC Investment Pte. Ltd.

Head office location: Singapore

Representative: Susumu Tsubaki

Founded: 2013

URL: AAIC Investment

Business Description:

Established in Singapore in 2013 as a fund management company of AAIC Holdings. Since 2014, it has supported the operation of CVCs (Corporate Venture Capital) for Japanese companies. In 2017, it established the first Japanese fund specializing in Africa (Africa Healthcare Fund, AHF-1), and invests mainly in the African healthcare sector. In 2022, it formed the Africa Innovation & Healthcare Fund (AHF-2), which had its first closing at the end of March 2022. As of April 2026, the two funds have invested in approximately 60 companies.

[Contact Information for this Press Release]

Company Name: AAIC Investment Pte. Ltd.

Name: Hiroki Ishida

Position: Representative of Kenya subsidiary, Director of Egypt subsidiary

Contact: pr-investment@ aa-ic.com

(Please remove the space after the "@" when contacting us)